市場調査レポート
商品コード
1660818

体外診断(IVD)の世界市場 2025~2029年

Global In-vitro Diagnostics (IVD) Market 2025-2029


出版日
発行
TechNavio
ページ情報
英文 260 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
体外診断(IVD)の世界市場 2025~2029年
出版日: 2025年02月14日
発行: TechNavio
ページ情報: 英文 260 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

体外診断(IVD)市場は2024-2029年に288億米ドル、予測期間中のCAGRは4.6%で成長すると予測されます。

当レポートでは、体外診断(IVD)市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、高齢者人口の増加、慢性疾患や感染症、個別化医療への需要、新製品の発売などによって牽引されています。

市場範囲
基準年 2025
終了年 2029
予測期間 2025-2029
成長モメンタム 加速
前年比2025年 4.3%
CAGR 4.6%
増分額 288億米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域別分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、今後数年間の体外診断(IVD)市場の成長を促進する主な要因の1つとして、高度治療ソリューションの世界の採用を挙げています。また、デジタル体外診断分野における技術革新や、ポイントオブケア分子診断への注目の高まりは、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavio別分析

  • 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • 混乱の要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2024
  • 市場の見通し 2024-2029

第5章 市場規模実績

  • 体外診断(IVD)の世界市場 2019-2023
  • 製品別タイプセグメント分析 2019-2023
  • 技術別セグメント分析 2019-2023
  • 用途別セグメント分析 2019-2023
  • エンドユーザー別セグメント分析 2019-2023
  • 地域別セグメント分析 2019-2023
  • 国別セグメント分析 2019-2023

第6章 定性分析

  • AIの影響:体外診断(IVD)の世界市場

第7章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第8章 市場セグメンテーション:製品タイプ別

  • 市場セグメント
  • 比較:製品タイプ別
  • 試薬とキット:市場規模と予測 2024-2029
  • 器械:市場規模と予測 2024-2029
  • その他:市場規模と予測 2024-2029
  • 市場機会:製品タイプ別

第9章 市場セグメンテーション:技術別

  • 市場セグメント
  • 比較:技術別
  • 免疫測定:市場規模と予測 2024-2029
  • 分子診断:市場規模と予測 2024-2029
  • 臨床化学:市場規模と予測 2024-2029
  • 血液学:市場規模と予測 2024-2029
  • その他:市場規模と予測 2024-2029
  • 市場機会:技術別

第10章 市場セグメンテーション:用途別

  • 市場セグメント
  • 比較:用途別
  • 腫瘍学:市場規模と予測 2024-2029
  • 心臓病学:市場規模と予測 2024-2029
  • 自己免疫疾患:市場規模と予測 2024-2029
  • 神経学:市場規模と予測 2024-2029
  • その他:市場規模と予測 2024-2029
  • 市場機会:用途別

第11章 市場セグメンテーション:エンドユーザー別

  • 市場セグメント
  • 比較:エンドユーザー別
  • 病院と診療所:市場規模と予測 2024-2029
  • 調査機関:市場規模と予測 2024-2029
  • 診断ラボ:市場規模と予測 2024-2029
  • その他:市場規模と予測 2024-2029
  • 市場機会:エンドユーザー別

第12章 顧客情勢

  • 顧客情勢の概要

第13章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2024-2029
  • 欧州:市場規模と予測 2024-2029
  • アジア:市場規模と予測 2024-2029
  • 世界のその他の地域:市場規模と予測 2024-2029
  • 米国:市場規模と予測 2024-2029
  • ドイツ:市場規模と予測 2024-2029
  • カナダ:市場規模と予測 2024-2029
  • 中国:市場規模と予測 2024-2029
  • 日本:市場規模と予測 2024-2029
  • 英国:市場規模と予測 2024-2029
  • フランス:市場規模と予測 2024-2029
  • インド:市場規模と予測 2024-2029
  • イタリア:市場規模と予測 2024-2029
  • ブラジル:市場規模と予測 2024-2029
  • 市場機会:地域情勢別

第14章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第15章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第16章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • ARKRAY Inc.
  • Becton Dickinson and Co.
  • BGI Genomics Co. Ltd.
  • Bio Rad Laboratories Inc.
  • BioMerieux SA
  • Danaher Corp.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Grifols SA
  • Illumina Inc.
  • QIAGEN N.V.
  • Quest Diagnostics Inc.
  • QuidelOrtho Corp.

第17章 付録

目次
Product Code: IRTNTR71317

The in-vitro diagnostics (IVD) market is forecasted to grow by USD 28.8 billion during 2024-2029, accelerating at a CAGR of 4.6% during the forecast period. The report on the in-vitro diagnostics (IVD) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing geriatric population, chronic and infectious diseases, demand for personalized medicine, and new product launches.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20254.3%
CAGR4.6%
Incremental Value$28.8 bn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's in-vitro diagnostics (IVD) market is segmented as below:

By Product Type

    • Reagents and kits
    • Instruments
    • Others

By Technology

    • Immunoassay
    • Molecular diagnostics
    • Clinical chemistry
    • Hematology
    • Others

By Application

    • Oncology
    • Cardiology
    • Autoimmune diseases
    • Neurology
    • Others

By End-user

    • Hospitals and clinics
    • Research institutes
    • Diagnostics laboratories
    • Others

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the global adoption of advanced treatment solutions as one of the prime reasons driving the in-vitro diagnostics (IVD) market growth during the next few years. Also, innovations in digital in-vitro diagnostics sector and increasing focus on point-of-care molecular diagnostics will lead to sizable demand in the market.

The report on the in-vitro diagnostics (IVD) market covers the following areas:

    • In-Vitro Diagnostics (IVD) Market sizing
    • In-Vitro Diagnostics (IVD) Market forecast
    • In-Vitro Diagnostics (IVD) Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading in-vitro diagnostics (IVD) market vendors that include Abbott Laboratories, Agilent Technologies Inc., ARKRAY Inc., Becton Dickinson and Co., BGI Genomics Co. Ltd., Bio RAD Laboratories Inc., BioMerieux SA, Charles River Laboratories International Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Grifols SA, Illumina Inc., Merck KGaA, QIAGEN N.V., Quest Diagnostics Inc., QuidelOrtho Corp., Siemens Healthineers AG, Sysmex Corp., and Thermo Fisher Scientific Inc.. Also, the in-vitro diagnostics (IVD) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Product Type
    • Executive Summary - Chart on Market Segmentation by Technology
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Global - Market size and forecast 2024-2029 ($ billion)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global In-Vitro Diagnostics (IVD) Market 2019 - 2023
    • Historic Market Size - Data Table on Global In-Vitro Diagnostics (IVD) Market 2019 - 2023 ($ billion)
  • 5.2 Product Type segment analysis 2019 - 2023
    • Historic Market Size - Product Type Segment 2019 - 2023 ($ billion)
  • 5.3 Technology segment analysis 2019 - 2023
    • Historic Market Size - Technology Segment 2019 - 2023 ($ billion)
  • 5.4 Application segment analysis 2019 - 2023
    • Historic Market Size - Application Segment 2019 - 2023 ($ billion)
  • 5.5 End-user segment analysis 2019 - 2023
    • Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
  • 5.6 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
  • 5.7 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ billion)

6 Qualitative Analysis

  • 6.1 Impact of AI on Global In-vitro Diagnostics (IVD) Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product Type

  • 8.1 Market segments
    • Chart on Product Type - Market share 2024-2029 (%)
    • Data Table on Product Type - Market share 2024-2029 (%)
  • 8.2 Comparison by Product Type
    • Chart on Comparison by Product Type
    • Data Table on Comparison by Product Type
  • 8.3 Reagents and kits - Market size and forecast 2024-2029
    • Chart on Reagents and kits - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Reagents and kits - Market size and forecast 2024-2029 ($ billion)
    • Chart on Reagents and kits - Year-over-year growth 2024-2029 (%)
    • Data Table on Reagents and kits - Year-over-year growth 2024-2029 (%)
  • 8.4 Instruments - Market size and forecast 2024-2029
    • Chart on Instruments - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Instruments - Market size and forecast 2024-2029 ($ billion)
    • Chart on Instruments - Year-over-year growth 2024-2029 (%)
    • Data Table on Instruments - Year-over-year growth 2024-2029 (%)
  • 8.5 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Others - Market size and forecast 2024-2029 ($ billion)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 8.6 Market opportunity by Product Type
    • Market opportunity by Product Type ($ billion)
    • Data Table on Market opportunity by Product Type ($ billion)

9 Market Segmentation by Technology

  • 9.1 Market segments
    • Chart on Technology - Market share 2024-2029 (%)
    • Data Table on Technology - Market share 2024-2029 (%)
  • 9.2 Comparison by Technology
    • Chart on Comparison by Technology
    • Data Table on Comparison by Technology
  • 9.3 Immunoassay - Market size and forecast 2024-2029
    • Chart on Immunoassay - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Immunoassay - Market size and forecast 2024-2029 ($ billion)
    • Chart on Immunoassay - Year-over-year growth 2024-2029 (%)
    • Data Table on Immunoassay - Year-over-year growth 2024-2029 (%)
  • 9.4 Molecular diagnostics - Market size and forecast 2024-2029
    • Chart on Molecular diagnostics - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Molecular diagnostics - Market size and forecast 2024-2029 ($ billion)
    • Chart on Molecular diagnostics - Year-over-year growth 2024-2029 (%)
    • Data Table on Molecular diagnostics - Year-over-year growth 2024-2029 (%)
  • 9.5 Clinical chemistry - Market size and forecast 2024-2029
    • Chart on Clinical chemistry - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Clinical chemistry - Market size and forecast 2024-2029 ($ billion)
    • Chart on Clinical chemistry - Year-over-year growth 2024-2029 (%)
    • Data Table on Clinical chemistry - Year-over-year growth 2024-2029 (%)
  • 9.6 Hematology - Market size and forecast 2024-2029
    • Chart on Hematology - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Hematology - Market size and forecast 2024-2029 ($ billion)
    • Chart on Hematology - Year-over-year growth 2024-2029 (%)
    • Data Table on Hematology - Year-over-year growth 2024-2029 (%)
  • 9.7 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Others - Market size and forecast 2024-2029 ($ billion)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 9.8 Market opportunity by Technology
    • Market opportunity by Technology ($ billion)
    • Data Table on Market opportunity by Technology ($ billion)

10 Market Segmentation by Application

  • 10.1 Market segments
    • Chart on Application - Market share 2024-2029 (%)
    • Data Table on Application - Market share 2024-2029 (%)
  • 10.2 Comparison by Application
    • Chart on Comparison by Application
    • Data Table on Comparison by Application
  • 10.3 Oncology - Market size and forecast 2024-2029
    • Chart on Oncology - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Oncology - Market size and forecast 2024-2029 ($ billion)
    • Chart on Oncology - Year-over-year growth 2024-2029 (%)
    • Data Table on Oncology - Year-over-year growth 2024-2029 (%)
  • 10.4 Cardiology - Market size and forecast 2024-2029
    • Chart on Cardiology - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Cardiology - Market size and forecast 2024-2029 ($ billion)
    • Chart on Cardiology - Year-over-year growth 2024-2029 (%)
    • Data Table on Cardiology - Year-over-year growth 2024-2029 (%)
  • 10.5 Autoimmune diseases - Market size and forecast 2024-2029
    • Chart on Autoimmune diseases - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Autoimmune diseases - Market size and forecast 2024-2029 ($ billion)
    • Chart on Autoimmune diseases - Year-over-year growth 2024-2029 (%)
    • Data Table on Autoimmune diseases - Year-over-year growth 2024-2029 (%)
  • 10.6 Neurology - Market size and forecast 2024-2029
    • Chart on Neurology - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Neurology - Market size and forecast 2024-2029 ($ billion)
    • Chart on Neurology - Year-over-year growth 2024-2029 (%)
    • Data Table on Neurology - Year-over-year growth 2024-2029 (%)
  • 10.7 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Others - Market size and forecast 2024-2029 ($ billion)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 10.8 Market opportunity by Application
    • Market opportunity by Application ($ billion)
    • Data Table on Market opportunity by Application ($ billion)

11 Market Segmentation by End-user

  • 11.1 Market segments
    • Chart on End-user - Market share 2024-2029 (%)
    • Data Table on End-user - Market share 2024-2029 (%)
  • 11.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 11.3 Hospitals and clinics - Market size and forecast 2024-2029
    • Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ billion)
    • Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
    • Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
  • 11.4 Research institutes - Market size and forecast 2024-2029
    • Chart on Research institutes - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Research institutes - Market size and forecast 2024-2029 ($ billion)
    • Chart on Research institutes - Year-over-year growth 2024-2029 (%)
    • Data Table on Research institutes - Year-over-year growth 2024-2029 (%)
  • 11.5 Diagnostics laboratories - Market size and forecast 2024-2029
    • Chart on Diagnostics laboratories - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Diagnostics laboratories - Market size and forecast 2024-2029 ($ billion)
    • Chart on Diagnostics laboratories - Year-over-year growth 2024-2029 (%)
    • Data Table on Diagnostics laboratories - Year-over-year growth 2024-2029 (%)
  • 11.6 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Others - Market size and forecast 2024-2029 ($ billion)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 11.7 Market opportunity by End-user
    • Market opportunity by End-user ($ billion)
    • Data Table on Market opportunity by End-user ($ billion)

12 Customer Landscape

  • 12.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Geographic Landscape

  • 13.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 13.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 13.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ billion)
    • Data Table on North America - Market size and forecast 2024-2029 ($ billion)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 13.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 13.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 13.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 13.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ billion)
    • Data Table on US - Market size and forecast 2024-2029 ($ billion)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 13.8 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 13.9 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 13.10 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ billion)
    • Data Table on China - Market size and forecast 2024-2029 ($ billion)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 13.11 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 13.12 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ billion)
    • Data Table on UK - Market size and forecast 2024-2029 ($ billion)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 13.13 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ billion)
    • Data Table on France - Market size and forecast 2024-2029 ($ billion)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 13.14 India - Market size and forecast 2024-2029
    • Chart on India - Market size and forecast 2024-2029 ($ billion)
    • Data Table on India - Market size and forecast 2024-2029 ($ billion)
    • Chart on India - Year-over-year growth 2024-2029 (%)
    • Data Table on India - Year-over-year growth 2024-2029 (%)
  • 13.15 Italy - Market size and forecast 2024-2029
    • Chart on Italy - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
    • Chart on Italy - Year-over-year growth 2024-2029 (%)
    • Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • 13.16 Brazil - Market size and forecast 2024-2029
    • Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
    • Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
    • Chart on Brazil - Year-over-year growth 2024-2029 (%)
    • Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • 13.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ billion)
    • Data Tables on Market opportunity By Geographical Landscape ($ billion)

14 Drivers, Challenges, and Opportunity/Restraints

  • 14.1 Market drivers
  • 14.2 Market challenges
  • 14.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 14.4 Market opportunities/restraints

15 Competitive Landscape

  • 15.1 Overview
  • 15.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 15.3 Landscape disruption
    • Overview on factors of disruption
  • 15.4 Industry risks
    • Impact of key risks on business

16 Competitive Analysis

  • 16.1 Companies profiled
    • Companies covered
  • 16.2 Company ranking index
    • Company ranking index
  • 16.3 Market positioning of companies
    • Matrix on companies position and classification
  • 16.4 Abbott Laboratories
    • Abbott Laboratories - Overview
    • Abbott Laboratories - Business segments
    • Abbott Laboratories - Key news
    • Abbott Laboratories - Key offerings
    • Abbott Laboratories - Segment focus
    • SWOT
  • 16.5 Agilent Technologies Inc.
    • Agilent Technologies Inc. - Overview
    • Agilent Technologies Inc. - Business segments
    • Agilent Technologies Inc. - Key news
    • Agilent Technologies Inc. - Key offerings
    • Agilent Technologies Inc. - Segment focus
    • SWOT
  • 16.6 ARKRAY Inc.
    • ARKRAY Inc. - Overview
    • ARKRAY Inc. - Product / Service
    • ARKRAY Inc. - Key offerings
    • SWOT
  • 16.7 Becton Dickinson and Co.
    • Becton Dickinson and Co. - Overview
    • Becton Dickinson and Co. - Business segments
    • Becton Dickinson and Co. - Key news
    • Becton Dickinson and Co. - Key offerings
    • Becton Dickinson and Co. - Segment focus
    • SWOT
  • 16.8 BGI Genomics Co. Ltd.
    • BGI Genomics Co. Ltd. - Overview
    • BGI Genomics Co. Ltd. - Product / Service
    • BGI Genomics Co. Ltd. - Key offerings
    • SWOT
  • 16.9 Bio Rad Laboratories Inc.
    • Bio Rad Laboratories Inc. - Overview
    • Bio Rad Laboratories Inc. - Business segments
    • Bio Rad Laboratories Inc. - Key news
    • Bio Rad Laboratories Inc. - Key offerings
    • Bio Rad Laboratories Inc. - Segment focus
    • SWOT
  • 16.10 BioMerieux SA
    • BioMerieux SA - Overview
    • BioMerieux SA - Business segments
    • BioMerieux SA - Key news
    • BioMerieux SA - Key offerings
    • BioMerieux SA - Segment focus
    • SWOT
  • 16.11 Danaher Corp.
    • Danaher Corp. - Overview
    • Danaher Corp. - Business segments
    • Danaher Corp. - Key news
    • Danaher Corp. - Key offerings
    • Danaher Corp. - Segment focus
    • SWOT
  • 16.12 DiaSorin SpA
    • DiaSorin SpA - Overview
    • DiaSorin SpA - Business segments
    • DiaSorin SpA - Key news
    • DiaSorin SpA - Key offerings
    • DiaSorin SpA - Segment focus
    • SWOT
  • 16.13 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
    • SWOT
  • 16.14 Grifols SA
    • Grifols SA - Overview
    • Grifols SA - Business segments
    • Grifols SA - Key news
    • Grifols SA - Key offerings
    • Grifols SA - Segment focus
    • SWOT
  • 16.15 Illumina Inc.
    • Illumina Inc. - Overview
    • Illumina Inc. - Business segments
    • Illumina Inc. - Key news
    • Illumina Inc. - Key offerings
    • Illumina Inc. - Segment focus
    • SWOT
  • 16.16 QIAGEN N.V.
    • QIAGEN N.V. - Overview
    • QIAGEN N.V. - Product / Service
    • QIAGEN N.V. - Key news
    • QIAGEN N.V. - Key offerings
    • SWOT
  • 16.17 Quest Diagnostics Inc.
    • Quest Diagnostics Inc. - Overview
    • Quest Diagnostics Inc. - Business segments
    • Quest Diagnostics Inc. - Key offerings
    • Quest Diagnostics Inc. - Segment focus
    • SWOT
  • 16.18 QuidelOrtho Corp.
    • QuidelOrtho Corp. - Overview
    • QuidelOrtho Corp. - Product / Service
    • QuidelOrtho Corp. - Key offerings
    • SWOT

17 Appendix

  • 17.1 Scope of the report
  • 17.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 17.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 17.4 Research methodology
    • Research methodology
  • 17.5 Data procurement
    • Information sources
  • 17.6 Data validation
    • Data validation
  • 17.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 17.8 Data synthesis
    • Data synthesis
  • 17.9 360 degree market analysis
    • 360 degree market analysis
  • 17.10 List of abbreviations
    • List of abbreviations